Evoke Pharma, Inc.
General ticker "EVOK" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $10.3M (TTM average)
Evoke Pharma, Inc. follows the US Stock Market performance with the rate: 33.9%.
Estimated limits based on current volatility of 0.6%: low 10.89$, high 10.95$
Factors to consider:
- Total employees count: 3 (-25.0%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Internal control weaknesses, Market competition, IT system failures, Climate change and natural disasters, Third-party risks
- Current price 67.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.44$, 6.55$]
- 2025-12-31 to 2026-12-31 estimated range: [1.66$, 4.59$]
Financial Metrics affecting the EVOK estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -58.93 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 40.17 <= 41.86
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Negative: negative Net income
Short-term EVOK quotes
Long-term EVOK plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2.51MM | $5.18MM | $10.25MM |
| Operating Expenses | $10.29MM | $12.61MM | $15.45MM |
| Operating Income | $-7.79MM | $-7.43MM | $-5.20MM |
| Non-Operating Income | $-0.44MM | $-0.72MM | $-0.30MM |
| Interest Expense | $0.50MM | $0.50MM | $0.50MM |
| R&D Expense | $0.30MM | $0.18MM | $0.02MM |
| Income(Loss) | $-8.22MM | $-8.15MM | $-5.50MM |
| Profit(Loss)* | $-8.22MM | $-7.79MM | $-5.35MM |
| Stockholders Equity | $4.08MM | $-2.58MM | $7.04MM |
| Inventory | $0.29MM | $0.48MM | $0.45MM |
| Assets | $11.85MM | $7.07MM | $17.52MM |
| Operating Cash Flow | $-6.60MM | $-4.98MM | $-5.46MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $7.29MM | $-0.12MM | $14.32MM |
| Earnings Per Share** | $-31.39 | $-27.97 | $-2.81 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.